DreaMed Wins FDA Clearance for CGM-Driven Insulin Automation Tool for Both Type 2 Injection Regimens
DreaMed Diabetes has received FDA 510(K) clearance for MODI, a mobile app that uses CGM (continuous glucose monitoring) data ...
Merck now has global rights to a SciBrunch Therapeutics drug candidate designed to block mutated versions of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results